Personal Information [ Top
Of Page ]
Anthony
Fenech graduated in Pharmacy in 1990 and read for a
Masters degree in Clinical Pharmacology from which
he graduated at the University of Malta in 1995.
He subsequently read for a PhD degree with the University of Nottingham, UK,
where he graduated in 2003.
His main research interest concerns pharmacogenetic
aspects of bronchial asthma.
He also currently sits on the
editorial board of The
Chronic*ill, the official journal of the Malta
College of Pharmacy Practice.
Fenech,
A., Zarb Adami, M. and Serracino Inglott, A. (1990)
Screening of Drug Interactions: a Computer-Assisted
Approach. International
Pharmacy Journal, 4,
252-254.
Fenech,
A.G. and Ellul-Micallef, R. (1997) Reactive Oxygen
Species and their Defence Mechanisms in Bronchial
Asthma. Life
Chemistry Reports, 15,
37-50.
Fenech,
A.G. and Ellul-Micallef, R. (1998)
Selenium, Glutathione Peroxidase and
Superoxide Dismutase in Maltese Asthmatic Patients:
Effect of Glucocorticoid Administration.
Pul. Pharmacol. Ther., 11,
301-308
Fenech
A.G., Ebejer, M.J., Felice, A.E., Ellul-Micallef,
R., Hall, I.P.
(1999).
Mutation Screening of the Human Muscarinic M2
Receptor in Maltese Asthmatic Patients.
Br. J.
Pharmacol., 128, 121P
Costello,
R.W., Wheatley, A., Fenech, A., Hall, I.P., Calverley,
P.M.A., Ikeda, A. Effect
of polymorphisms of the M2 muscarinic
receptor on vagally-induced bronchoconstriction. [Poster
E44, presented at the American Thoracic Society
international conference, held at Toronto, Canada,
2000].
Fenech,
A.G., Wheatley, A.P., Ebejer, M.J., Felice, A.E., Ellul-Micallef, R., Hall, I.P.
Mutation screening of the Human M2 and M3 receptor genes
in normal and asthmatic individuals. [Peer-reviewed poster presented at the
British Pharmacological Society winter meeting held at the University of
Birmingham, 2000].
Fenech, A.G., Wheatley, A., Ebejer, M.J.,
Felice, A.E., Ellul-Micallef, R., Hall, I.P. (2001).
Transmission disequilibrium testing for a muscarinic M2
receptor 3’ untranslated region single nucleotide polymorphism within
asthmatic families. [Poster K83,
presented at the American Thoracic Society international conference, held at San
Francisco, USA, 2001].
Billington, C.K., Swan, C., Wheatley, A.P.,
Fenech, A., Hewitt, J, Hall, I.P.
Organisation of the 5’ untranslated region of
the human M2 muscarinic receptor gene.
[Poster 612 presented at the American Thoracic Society
summer meeting, held at San Francisco, USA, 2001].
Fenech, A.G., Ebejer, M.J., Felice, A.E.,
Ellul-Micallef, R., Hall, I.P. (2001).
Mutation screening of the muscarinic M2 and M3
receptor genes in normal and asthmatic subjects.
Br. J.
Pharmacol. 133:
43-38.
Fenech, A., Hall, I.P. (2002).
Pharmacogenetics of asthma. Br. J. Clin.
Pharm. 53: 3-15.
Cordina,
M., McElnay, J.C., Hughes, C.M., Fenech, A.G. (2002)
Health-related issues of importance to school children
with asthma - A qualitative study. Journal of
Social and Administrative Pharmacy 19: 162-9
Fenech A.G., Billington, C.K.,
Swan, C., Richards, S., Hunter, T., Ebejer, M.J.,
Felice, A.E., Ellul-Micallef, R., Hall, I.P. (2004)
Novel Polymorphisms Influencing Transcription of the
Human CHRM2 Gene in Airway Smooth Muscle. Am. J.
Respir. Cell Mol. Biol. 30: 678–86
Fenech A.G., Ellul-Micallef, R.
(2005) Pharmacogenetics of asthma therapeutics. The Chronic*ill
Issue 9, 24-8
-
British Pharmacological Society
-
European Respiratory Society
-
Malta College of
Pharmacy Practice
|
